Lunit SCOPE IO Reveals Promising Results in Neoadjuvant Immunotherapy Study for Head and Neck Cancer Patients : vimarsana.com

New research published in Clinical Cancer Research shows significant improvement in distant recurrence-free survival with combined durvalumab and tremelimumab treatment, supported by Lunit SCOPE IO’s analysis of tumor microenvironment

Related Keywords

Seoul , Soult Ukpyolsi , South Korea , United States , American , Hyun Wook Kim , Brandon Suh , Kim Hye Ryun , Hye Ryun Kim , Hee Hong , American Association For Cancer Research , Clinical Cancer Research , Department Of Otolaryngology Prof , Neck Cancer Center Department Of Oncology Prof , Yonsei University College Of Medicine , Department Of Pathology Prof , American Association , Cancer Research , Yonsei Cancer Hospital Head , Neck Cancer Center Department , Min Hee Hong , Chang Gon Kim , Yoon Woo Koh , Sun Och Yoon , Yonsei University College , Professor Kim Hye Ryun ,